Search

Ian J Lobo

Examiner (ID: 16049, Phone: (571)272-6974 , Office: P/3645 )

Most Active Art Unit
3645
Art Unit(s)
3662, 3641, 2202, 3642, 2838, 2201, 3645, 2899
Total Applications
3412
Issued Applications
2797
Pending Applications
152
Abandoned Applications
463

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 923039 [patent_doc_number] => 07319011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)' [patent_app_type] => utility [patent_app_number] => 11/100640 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10957 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319011.pdf [firstpage_image] =>[orig_patent_app_number] => 11100640 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/100640
Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC) Apr 6, 2005 Issued
Array ( [id] => 7121996 [patent_doc_number] => 20050013825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Vaccine containing the catalytic subunit of telomerase for treating cancer' [patent_app_type] => utility [patent_app_number] => 10/877146 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 104 [patent_no_of_words] => 103028 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10877146 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/877146
Vaccine containing the catalytic subunit of telomerase for treating cancer Jun 23, 2004 Abandoned
Array ( [id] => 7082688 [patent_doc_number] => 20050048068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Therapeutic compounds for ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/813859 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19390 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048068.pdf [firstpage_image] =>[orig_patent_app_number] => 10813859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/813859
Therapeutic compounds for ovarian cancer Mar 30, 2004 Abandoned
Array ( [id] => 7024937 [patent_doc_number] => 20050019331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents' [patent_app_type] => utility [patent_app_number] => 10/718930 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4697 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019331.pdf [firstpage_image] =>[orig_patent_app_number] => 10718930 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/718930
Synthetic peptide neutrophil cell chemotactic agents Nov 19, 2003 Abandoned
Array ( [id] => 7289340 [patent_doc_number] => 20040110219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods for diagnosis and therapy of pancreatic cancer and composition useful therein' [patent_app_type] => new [patent_app_number] => 10/696487 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6113 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110219.pdf [firstpage_image] =>[orig_patent_app_number] => 10696487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/696487
Methods for diagnosis and therapy of pancreatic cancer and composition useful therein Oct 28, 2003 Issued
Array ( [id] => 7199054 [patent_doc_number] => 20040086455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Detection and treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/688464 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10442 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086455.pdf [firstpage_image] =>[orig_patent_app_number] => 10688464 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/688464
Detection and treatment of cancer Oct 16, 2003 Abandoned
Array ( [id] => 6905604 [patent_doc_number] => 20050100999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Nucleic acid encoding receptor type protein kinase' [patent_app_type] => utility [patent_app_number] => 10/653147 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6878 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100999.pdf [firstpage_image] =>[orig_patent_app_number] => 10653147 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/653147
Nucleic acid encoding receptor type protein kinase Sep 2, 2003 Abandoned
Array ( [id] => 7083114 [patent_doc_number] => 20050048494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Colorectal cancer prognostics' [patent_app_type] => utility [patent_app_number] => 10/651237 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7951 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048494.pdf [firstpage_image] =>[orig_patent_app_number] => 10651237 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651237
Colorectal cancer prognostics Aug 26, 2003 Abandoned
10/332923 Method of detecting an increased susceptibility to breast cancer May 14, 2003 Abandoned
Array ( [id] => 7289405 [patent_doc_number] => 20040110239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Detection to the HER2 receptor by means of biotinilated humanized antibody' [patent_app_type] => new [patent_app_number] => 10/417336 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4175 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110239.pdf [firstpage_image] =>[orig_patent_app_number] => 10417336 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/417336
Detection to the HER2 receptor by means of biotinilated humanized antibody Apr 16, 2003 Abandoned
Array ( [id] => 6769921 [patent_doc_number] => 20030215861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods of treating a BRCA associated disorder' [patent_app_type] => new [patent_app_number] => 10/410207 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5627 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215861.pdf [firstpage_image] =>[orig_patent_app_number] => 10410207 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/410207
Methods of treating a BRCA associated disorder Apr 9, 2003 Abandoned
Array ( [id] => 7429009 [patent_doc_number] => 20040001789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof' [patent_app_type] => new [patent_app_number] => 10/403516 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001789.pdf [firstpage_image] =>[orig_patent_app_number] => 10403516 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/403516
Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof Mar 30, 2003 Abandoned
Array ( [id] => 7467539 [patent_doc_number] => 20040053830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'BCMP84 protein, compositions, diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/382478 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38403 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053830.pdf [firstpage_image] =>[orig_patent_app_number] => 10382478 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/382478
BCMP84 protein, compositions, diagnostic and therapeutic uses thereof Mar 5, 2003 Abandoned
Array ( [id] => 7364835 [patent_doc_number] => 20040005644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method and composition for detection and treatment of breast cancer' [patent_app_type] => new [patent_app_number] => 10/373801 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29841 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005644.pdf [firstpage_image] =>[orig_patent_app_number] => 10373801 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/373801
Method and composition for detection and treatment of breast cancer Feb 26, 2003 Abandoned
Array ( [id] => 6804662 [patent_doc_number] => 20030232056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Compositions and methods for the therapy and diagnosis of ovarian cancer' [patent_app_type] => new [patent_app_number] => 10/369186 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46416 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232056.pdf [firstpage_image] =>[orig_patent_app_number] => 10369186 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/369186
Compositions and methods for the therapy and diagnosis of ovarian cancer Feb 13, 2003 Abandoned
Array ( [id] => 6769954 [patent_doc_number] => 20030215894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Protein-induced monoclonal receptors to protein ligands' [patent_app_type] => new [patent_app_number] => 10/350405 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 36814 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215894.pdf [firstpage_image] =>[orig_patent_app_number] => 10350405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/350405
Protein-induced monoclonal receptors to protein ligands Jan 23, 2003 Abandoned
Array ( [id] => 6739716 [patent_doc_number] => 20030157085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Antitumor agents' [patent_app_type] => new [patent_app_number] => 10/314439 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4526 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157085.pdf [firstpage_image] =>[orig_patent_app_number] => 10314439 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/314439
Antitumor agents Dec 8, 2002 Abandoned
Array ( [id] => 6851445 [patent_doc_number] => 20030143648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Enzyme activity profiles' [patent_app_type] => new [patent_app_number] => 10/304559 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 13145 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143648.pdf [firstpage_image] =>[orig_patent_app_number] => 10304559 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/304559
Enzyme activity profiles Nov 24, 2002 Abandoned
Array ( [id] => 7395719 [patent_doc_number] => 20040022785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth' [patent_app_type] => new [patent_app_number] => 10/302663 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26201 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022785.pdf [firstpage_image] =>[orig_patent_app_number] => 10302663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/302663
Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth Nov 21, 2002 Abandoned
Array ( [id] => 7329741 [patent_doc_number] => 20040254101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Colon specific gene and protein and cancer' [patent_app_type] => new [patent_app_number] => 10/291773 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 79201 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254101.pdf [firstpage_image] =>[orig_patent_app_number] => 10291773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/291773
Colon specific gene and protein and cancer Nov 11, 2002 Abandoned
Menu